Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/panel-testing-for-hereditary-breast-cancer-more-or-less-TN7vW7z8CD
References (54)
-
S. Buys, J. Sandbach, A. Gammon, G. Patel, J. Kidd, K. Brown, L. Sharma, J. Saam, J. Lancaster, M. Daly (2017)
A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genesCancer, 123
-
K. Lu, M. Wood, M. Daniels, C. Burke, J. Ford, N. Kauff, W. Kohlmann, N. Lindor, T. Mulvey, L. Robinson, W. Rubinstein, E. Stoffel, C. Snyder, S. Syngal, Janette Merrill, D. Wollins, K. Hughes (2014)
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 8
-
M. Jenkins, Marina Croitoru, N. Monga, S. Cleary, M. Cotterchio, J. Hopper, S. Gallinger (2006)
Risk of Colorectal Cancer in Monoallelic and Biallelic Carriers of MYH Mutations: A Population-Based Case-Family StudyCancer Epidemiology Biomarkers & Prevention, 15
-
M. Daly, R. Pilarski, Michael Berry, S. Buys, Meagan Farmer, S. Friedman, J. Garber, N. Kauff, S. Khan, C. Klein, W. Kohlmann, A. Kurian, J. Litton, L. Madlensky, S. Merajver, K. Offit, T. Pal, Gwen Reiser, K. Shannon, E. Swisher, S. Vinayak, Nicoleta Voian, J. Weitzel, M. Wick, G. Wiesner, M. Dwyer, S. Darlow (2017)
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Journal of the National Comprehensive Cancer Network : JNCCN, 15 1
-
A. Kurian, K. Ward, N. Howlader, D. Deapen, A. Hamilton, A. Mariotto, Daniel Miller, Lynne Penberthy, S. Katz (2019)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37 15
-
M. Metzker (2010)
Sequencing technologies — the next generationNature Reviews Genetics, 11
-
M. Swift, D. Morrell, Ruby Massey, C. Chase (1991)
Incidence of cancer in 161 families affected by ataxia-telangiectasia.The New England journal of medicine, 325 26
-
A. Kurian, Yun Li, A. Hamilton, K. Ward, S. Hawley, M. Morrow, M. McLeod, R. Jagsi, S. Katz (2017)
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 20
-
M. Robson, A. Bradbury, B. Arun, S. Domchek, J. Ford, H. Hampel, Stephen Lipkin, S. Syngal, D. Wollins, N. Lindor (2010)
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 31
-
N. Carbine, Liz Lostumbo, J. Wallace, Henry Ko (2018)
Risk-reducing mastectomy for the prevention of primary breast cancer.The Cochrane database of systematic reviews, 4
-
D. Easton, L. McGuffog, D. Thompson, A. Dunning, L. Tee, C. Baynes, C. Healey, P. Pharoah, B. Ponder, S. Seal, R. Barfoot, N. Sodha, R. Eeles, M. Stratton, N. Rahman, J. Peto, A. Spurdle, Xiaoqing Chen, G. Chenevix-Trench, J. Hopper, G. Giles, M. Mccredie, K. Syrjäkoski, K. Holli, O. Kallioniemi, H. Eerola, P. Vahteristo, C. Blomqvist, H. Nevanlinna, V. Kataja, A. Mannermaa, T. Dörk, M. Bremer, P. Devilee, G. Bock, E. Krol-Warmerdam, K. Kroese-Jansema, P. Wijers-Koster, C. Cornelisse, R. Tollenaar, H. Meijers-Heijboer, E. Berns, J. Nagel, J. Foekens, J. Klijn, M. Schutte, Chek Cons (2004)
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.American journal of human genetics, 74 6
-
Katarzyna Jerzak, T. Mancuso, Andrea Eisen (2018)
Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review.Current oncology, 25 2
-
K. Passaperuma, E. Warner, P. Causer, K. Hill, S. Messner, J. Wong, R. Jong, F. Wright, M. Yaffe, E. Ramsay, S. Balasingham, L. Verity, A. Eisen, B. Curpen, R. Shumak, D. Plewes, S. Narod (2012)
Long-term results of screening with magnetic resonance imaging in women with BRCA mutationsBritish Journal of Cancer, 107
-
N. Tung, N. Lin, J. Kidd, Brian Allen, Nanda Singh, R. Wenstrup, A. Hartman, E. Winer, J. Garber (2016)
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 13
-
M. Ahmed, N. Rahman (2006)
ATM and breast cancer susceptibilityOncogene, 25
-
P. Beitsch, P. Whitworth, K. Hughes, Rakesh Patel, B. Rosen, G. Compagnoni, P. Baron, R. Simmons, L. Smith, I. Grady, M. Kinney, C. Coomer, K. Barbosa, D. Holmes, E. Brown, L. Gold, Patricia Clark, L. Riley, S. Lyons, A. Ruíz, S. Kahn, H. Macdonald, L. Curcio, M. Hardwick, Shan Yang, E. Esplin, R. Nussbaum (2018)
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?Journal of Clinical Oncology, 37
-
M. Schmidt, F. Hogervorst, R. Hien, S. Cornelissen, A. Broeks, M. Adank, H. Meijers, Q. Waisfisz, A. Hollestelle, M. Schutte, A. Ouweland, M. Hooning, I. Andrulis, H. Anton-Culver, N. Antonenkova, A. Antoniou, V. Arndt, M. Bermisheva, N. Bogdanova, M. Bolla, H. Brauch, H. Brenner, T. Brüning, B. Burwinkel, J. Chang-Claude, G. Chenevix-Trench, F. Couch, A. Cox, S. Cross, K. Czene, A. Dunning, P. Fasching, J. Figueroa, O. Fletcher, H. Flyger, E. Galle, M. García-Closas, G. Giles, L. Haeberle, P. Hall, P. Hillemanns, J. Hopper, A. Jakubowska, E. John, Michael Jones, E. Khusnutdinova, J. Knight, V. Kosma, V. Kristensen, Andrew Lee, A. Lindblom, J. Lubiński, A. Mannermaa, S. Margolin, A. Meindl, R. Milne, T. Muranen, P. Newcomb, K. Offit, T. Park-Simon, J. Peto, P. Pharoah, M. Robson, A. Rudolph, E. Sawyer, R. Schmutzler, C. Seynaeve, J. Soens, M. Southey, A. Spurdle, H. Surowy, A. Swerdlow, R. Tollenaar, I. Tomlinson, A. Trentham-Dietz, C. Vachon, Qin Wang, A. Whittemore, A. Ziogas, L. Kolk, H. Nevanlinna, T. Dörk, S. Bojesen, D. Easton (2016)
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 23
-
G. Bougeard, M. Renaux‐Petel, J. Flaman, C. Charbonnier, Pierre Fermey, Muriel Belotti, M. Gauthier‐Villars, D. Stoppa-Lyonnet, É. Consolino, L. Brugières, O. Caron, P. Benusiglio, B. Paillerets, V. Bonadona, C. Bonaïti‐pellié, J. Tinat, S. Baert-Desurmont, T. Frebourg (2015)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 21
-
M. Robson, S. Im, E. Senkus, Bing-he Xu, S. Domchek, N. Masuda, S. Delaloge, Wei Li, N. Tung, A. Armstrong, Wenting Wu, C. Goessl, S. Runswick, P. Conte (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationThe New England Journal of Medicine, 377
-
A. Kurian, K. Griffith, A. Hamilton, K. Ward, M. Morrow, S. Katz, R. Jagsi (2017)
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast CancerJAMA, 317
-
M. Wood, P. Kadlubek, T. Pham, D. Wollins, K. Lu, J. Weitzel, M. Neuss, K. Hughes (2014)
Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 8
-
Tasleem Padamsee, C. Wills, L. Yee, E. Paskett (2017)
Decision making for breast cancer prevention among women at elevated riskBreast Cancer Research : BCR, 19
-
B. Crawford, Sophie Adams, T. Sittler, J. Akker, Salina Chan, O. Leitner, L. Ryan, E. Gil, L. Veer (2017)
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patientsBreast Cancer Research and Treatment, 163
-
J. Lancaster, C. Powell, N. Kauff, I. Cass, Lee-may Chen, K. Lu, D. Mutch, A. Berchuck, B. Karlan, T. Herzog (2015)
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.Gynecologic oncology, 136 1
-
D. Mandelker, Liying Zhang, Y. Kemel, Z. Stadler, V. Joseph, A. Zehir, Nisha Pradhan, A. Arnold, M. Walsh, Yirong Li, A. Balakrishnan, Aijazuddin Syed, Meera Prasad, K. Nafa, M. Carlo, K. Cadoo, M. Sheehan, M. Fleischut, E. Salo-Mullen, Magan Trottier, S. Lipkin, Anne Lincoln, Semanti Mukherjee, Vignesh Ravichandran, R. Cambria, J. Galle, W. Abida, M. Arcila, R. Benayed, Ronak Shah, Kenneth Yu, D. Bajorin, J. Coleman, S. Leach, M. Lowery, J. García-Aguilar, P. Kantoff, C. Sawyers, M. Dickler, L. Saltz, R. Motzer, E. O’Reilly, H. Scher, J. Baselga, D. Klimstra, D. Solit, D. Hyman, M. Berger, M. Ladanyi, M. Robson, K. Offit (2017)
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingJAMA, 318
-
Caiqian Cropper, A. Woodson, B. Arun, C. Barcenas, J. Litton, S. Noblin, Diane Liu, Minjeong Park, M. Daniels (2017)
Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.Journal of the National Comprehensive Cancer Network : JNCCN, 15 6
-
E. Warner, K. Hill, P. Causer, D. Plewes, R. Jong, M. Yaffe, W. Foulkes, P. Ghadirian, H. Lynch, F. Couch, J. Wong, F. Wright, P. Sun, S. Narod (2011)
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 13
-
Aung Win, J. Dowty, S. Cleary, Hyeja Kim, D. Buchanan, Joanne Young, M. Clendenning, C. Rosty, R. MacInnis, G. Giles, A. Boussioutas, F. Macrae, S. Parry, J. Goldblatt, J. Baron, Terrilea Burnett, L. Marchand, P. Newcomb, R. Haile, J. Hopper, M. Cotterchio, S. Gallinger, N. Lindor, K. Tucker, I. Winship, M. Jenkins (2014)
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.Gastroenterology, 146 5
-
Maren Weischer, S. Bojesen, C. Ellervik, A. Tybjaerg-hansen, B. Nordestgaard (2008)
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 4
-
A. Chiba, T. Hoskin, E. Hallberg, Jodie Cogswell, C. Heins, F. Couch, J. Boughey (2016)
Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast CancerAnnals of Surgical Oncology, 23
-
S. Heymann, S. Delaloge, A. Rahal, O. Caron, T. Frebourg, L. Barreau, C. Pachet, M. Mathieu, H. Marsiglia, C. Bourgier (2010)
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeRadiation Oncology (London, England), 5
-
C. Kuhl, S. Weigel, S. Schrading, B. Arand, H. Bieling, R. König, B. Tombach, C. Leutner, A. Rieber-Brambs, D. Nordhoff, W. Heindel, M. Reiser, H. Schild (2010)
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 9
-
M. Suszyńska, K. Klonowska, A. Jasinska, P. Kozłowski (2019)
Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.Gynecologic oncology, 153 2
-
H. Hampel, R. Bennett, A. Buchanan, R. Pearlman, G. Wiesner (2014)
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessmentGenetics in Medicine, 17
-
Rachel, J., Elsby, Michael, P., Kahn (2004)
United States Court of Appeals for the Federal Circuit -
D. Owens, K. Davidson, A. Krist, M. Barry, M. Cabana, A. Caughey, Chyke Doubeni, J. Epling, Martha Kubik, C. Landefeld, C. Mangione, L. Pbert, Michael Silverstein, M. Simon, Chien-Wen Tseng, J. Wong (2019)
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.JAMA, 322 7
-
N. Elsayegh, Rachel Webster, A. Barrera, Heather Lin, H. Kuerer, J. Litton, I. Bedrosian, B. Arun (2018)
Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancerCancer Medicine, 7
-
C. Childers, K. Childers, M. Maggard-gibbons, J. Macinko (2017)
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 34
-
J. Litton, H. Rugo, J. Ettl, S. Hurvitz, A. Gonçalves, Kyung-Hun Lee, L. Fehrenbacher, R. Yerushalmi, L. Mina, Miguel Martín, H. Roché, Y. Im, R. Quek, D. Markova, I. Tudor, A. Hannah, W. Eiermann, J. Blum (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA MutationThe New England Journal of Medicine, 379
-
Professor Southey, D. Goldgar, R. Winqvist, K. Pylkäs, F. Couch, M. Tischkowitz, W. Foulkes, J. Dennis, K. Michailidou, E. Rensburg, T. Heikkinen, H. Nevanlinna, J. Hopper, T. Dörk, K. Claes, J. Reis-Filho, Z. Teo, P. Radice, Irene Catucci, P. Peterlongo, H. Tsimiklis, F. Odefrey, J. Dowty, M. Schmidt, A. Broeks, F. Hogervorst, S. Verhoef, Jane Carpenter, Christina Clarke, Rodney Scott, P. Fasching, L. Haeberle, A. Ekici, M. Beckmann, J. Peto, O. Fletcher, N. Johnson, M. Bolla, E. Sawyer, I. Tomlinson, M. Kerin, N. Miller, F. Marmé, B. Burwinkel, Rongxi Yang, P. Guénel, Thérèse Truong, F. Menegaux, M. Sanchez, S. Bojesen, S. Nielsen, H. Flyger, J. Benítez, Pilar Zamora, J. Peŕez, P. Menéndez, H. Anton-Culver, S. Neuhausen, A. Ziogas, Christina Clarke, H. Brenner, V. Arndt, C. Stegmaier, H. Brauch, T. Brüning, Y. Ko, T. Muranen, K. Aittomäki, C. Blomqvist, N. Bogdanova, N. Antonenkova, A. Lindblom, S. Margolin, A. Mannermaa, V. Kataja, V. Kosma, J. Hartikainen, A. Spurdle, E. Wauters, D. Smeets, B. Beuselinck, G. Floris, J. Chang-Claude, A. Rudolph, P. Seibold, D. Flesch-Janys, J. Olson, C. Vachon, V. Pankratz, C. Mclean, C. Haiman, B. Henderson, F. Schumacher, L. Marchand, V. Kristensen, G. Alnæs, W. Zheng, D. Hunter, S. Lindstrom, S. Hankinson, P. Kraft, Irene Andrulis, Julia Knight, G. Glendon, A. Mulligan, A. Jukkola-Vuorinen, Mervi Grip, S. Kauppila, P. Devilee, E. Tollenaar, C. Seynaeve, A. Hollestelle, M. García-Closas, Jonine Figueroa, Stephen Chanock, J. Lissowska, K. Czene, Hatef Darabi, M. Eriksson, D. Eccles, Sajjad Rafiq, W. Tapper, S. Gerty, M. Hooning, John Martens, M. Collée, M. Tilanus-Linthorst, Jingmei Li, Judith Brand, K. Humphreys, A. Cox, M. Reed, C. Luccarini, C. Baynes, A. Dunning, U. Hamann, Diana Torres, H. Ulmer, T. Rüdiger, A. Jakubowska, Lubiński, Katarzyna Jaworska, K. Durda, S. Slager, A. Toland, C. Ambrosone, D. Yannoukakos, A. Swerdlow, A. Ashworth, N. Orr, Michael Jones, A. González-Neira, G. Pita, R. Alonso, N. Álvarez, D. Herrero, D. Tessier, Daniel Vincent, F. Bacot, J. Simard, M. Dumont, P. Soucy, R. Eeles, K. Muir, F. Wiklund, H. Gronberg, J. Schleutker, B. Nordestgaard, Maren Weischer, R. Travis, D. Neal, J. Donovan, F. Hamdy, K. Khaw, J. Stanford, W. Blot, S. Thibodeau, D. Schaid, J. Kelley, C. Maier, A. Kibel, C. Cybulski, L. Cannon-Albright, Katja Butterbach, Jong Park, R. Kaneva, J. Batra, M. Teixeira, Z. Kote-Jarai, Ali Amin, A. Olama, S. Benlloch, S. Renner, A. Hartmann, A. Hein, M. Ruebner, D. Lambrechts, E. Nieuwenhuysen, I. Vergote, Sandrina Lambretchs, J. Doherty, M. Rossing, S. Nickels, U. Eilber, S. Wang-gohrke, K. Odunsi, Lara Sucheston-Campbell, Grace Friel, G. Lurie, J. Killeen, L. Wilkens, M. Goodman, I. Runnebaum, P. Hillemanns, Liisa Pelttari, R. Butzow, F. Modugno, R. Edwards, R. Ness, K. Moysich, A. Bois, F. Heitz, P. Harter, S. Kommoss, B. Karlan, C. Walsh, J. Lester, A. Jensen, S. Kjaer, E. Høgdall, B. Peissel, B. Bonanni, L. Bernard, E. Goode, B. Fridley, R. Vierkant, J. Cunningham, M. Larson, Z. Fogarty, K. Kalli, Dong Liang, K. Lu, M. Hildebrandt, Xifeng Wu, D. Levine, F. Dao, Maria Bisogna, A. Berchuck, E. Iversen, J. Marks, L. Akushevich, D. Cramer, J. Schildkraut, K. Terry, E. Poole, M. Stampfer, S. Tworoger, E. Bandera, I. Orlow, S. Olson, L. Bjørge, H. Salvesen, A. Altena, K. Aben, L. Kiemeney, G. LeonFA, Massuger, T. Pejovic, Yukie Bean, A. Brooks-Wilson, L. Kelemen, L. Cook, N. Le, B. Górski, J. Gronwald, J. Menkiszak, C. Høgdall, L. Lundvall, L. Nedergaard, S. Engelholm, E. Dicks, J. Tyrer, I. Campbell, I. McNeish, J. Paul, N. Siddiqui, R. Glasspool, A. Whittemore, J. Rothstein, V. McGuire, W. Sieh, H. Cai, X. Shu, R. Teten, R. Sutphen, J. McLaughlin, S. Narod, C. Phelan, A. Monteiro, D. Fenstermacher, Hui-Yi Lin, J. Permuth, T. Sellers, Ann Chen, Ya‐Yu Tsai, Zhihua Chen, A. Gentry-Maharaj, S. Gayther, S. Ramus, U. Menon, Anna Wu, C. Pearce, D. Berg, M. Pike, A. Dansonka-Mieszkowska, Joanna Plisiecka-Hałasa, J. Moes-Sosnowska, J. Kupryjańczyk, P. Pharoah, Honglin Song, I. Winship, G. Chenevix-Trench, G. Giles, S. Tavtigian, D. Easton, R. Milne (2016)
PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS -
S. Ingham, M. Sperrin, A. Baildam, G. Ross, R. Clayton, F. Lalloo, I. Buchan, A. Howell, D. Evans (2013)
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralBreast Cancer Research and Treatment, 142
-
E. Manahan, H. Kuerer, M. Sebastian, K. Hughes, J. Boughey, D. Euhus, S. Boolbol, Walton Taylor (2019)
Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast SurgeonsAnnals of Surgical Oncology, 26
-
A. Finch, J. Lubiński, P. Møller, C. Singer, B. Karlan, L. Senter, B. Rosen, L. Maehle, P. Ghadirian, C. Cybulski, T. Huzarski, A. Eisen, W. Foulkes, C. Kim-sing, P. Ainsworth, N. Tung, H. Lynch, S. Neuhausen, K. Metcalfe, I. Thompson, Joan Murphy, P. Sun, S. Narod (2014)
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 15
-
M. Schutte, S. Seal, R. Barfoot, H. Meijers-Heijboer, Marijke Wasielewski, D. Evans, D. Eccles, C. Meijers, F. Lohman, J. Klijn, A. Ouweland, P. Futreal, K. Nathanson, B. Weber, D. Easton, Michael Stratton, N. Rahman (2003)
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.American journal of human genetics, 72 4
-
C. Espenschied, H. LaDuca, Shuwei Li, R. McFarland, C. Gau, H. Hampel (2017)
Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 22
-
K. Theobald, L. Susswein, Megan Marshall, M. Roberts, J. Mester, Darrow Speyer, Ravin Williams, Sara Knapke, S. Solomon, P. Murphy, Rachel Klein, K. Hruska, B. Solomon (2018)
Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer DiagnosisAnnals of Surgical Oncology, 25
-
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy (2018)
Role of BRCA Mutations in the Modulation of Response to Platinum TherapyFrontiers in Oncology, 8
-
F. Couch, Hermela Shimelis, Chunling Hu, S. Hart, E. Polley, Jie Na, E. Hallberg, R. Moore, Abigail Thomas, J. Lilyquist, B. Feng, R. McFarland, T. Pesaran, Robert Huether, H. LaDuca, E. Chao, D. Goldgar, Jill Dolinsky (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerJAMA Oncology, 3
-
S. Domchek, T. Friebel, C. Singer, D. Evans, H. Lynch, C. Isaacs, J. Garber, S. Neuhausen, E. Matloff, R. Eeles, G. Pichert, Laura t'veer, N. Tung, J. Weitzel, F. Couch, W. Rubinstein, P. Ganz, M. Daly, O. Olopade, G. Tomlinson, J. Schildkraut, J. Blum, T. Rebbeck (2010)
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.JAMA, 304 9
-
(2019)
An important paper which demonstrates that guidelines do identifiy women with BRCA mutations, but expanding testing guidelines may reach more mutation carriers -
E. O'Leary, Daniela Iacoboni, J. Holle, Scott Michalski, E. Esplin, Shan Yang, Karen Ouyang (2017)
Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer RiskAnnals of Surgical Oncology, 24
-
S. Yadav, A. Reeves, Sarah Campian, Amy Paine, D. Zakalik (2017)
Outcomes of retesting BRCA negative patients using multigene panelsFamilial Cancer, 16
-
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations -
E. Gabai-Kapara, A. Lahad, B. Kaufman, E. Friedman, S. Segev, P. Renbaum, R. Beeri, M. Gal, J. Grinshpun‐Cohen, Karen Djemal, Jessica Mandell, Ming Lee, U. Beller, R. Catane, M. King, E. Levy-Lahad (2014)
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2Proceedings of the National Academy of Sciences, 111
- Publisher
- Springer Journals
- Copyright
- Copyright © Springer Science+Business Media, LLC, part of Springer Nature 2020
- ISSN
- 1943-4588
- eISSN
- 1943-4596
- DOI
- 10.1007/s12609-020-00361-4
- Publisher site
- See Article on Publisher Site
Abstract
Purpose of ReviewPanel testing is increasingly being offered to patients. Currently, women may be offered a panel of up to 80 genes. Oncologists are tasked with understanding the indications for this testing as well as the potential implications. In this review, we outline which patients should undergo genetic testing for hereditary breast cancer, when this testing should be performed, and which genes should be tested for.Recent FindingsOur understanding of hereditary breast cancer has drastically changed with the advent of next generation sequencing (NGS), and many additional genes have been associated with increased breast cancer risk. Some have advocated for genetic testing of all women with breast cancer.SummaryRoutine genetic testing for all women with breast cancer is not warranted. Women with a phenotype associated with hereditary breast cancer, with a family history of cancer, or for whom a positive genetic test would change management should be offered genetic testing.
Journal
Current Breast Cancer Reports – Springer Journals
Published: Jun 20, 2020